Citations 1
S5 Sustained Improvements in Health-Related Quality of Life Outcomes With Long-Term Risankizumab Treatment in Patients With Moderately to Severely Active Crohn’s Disease: Results from the FORTIFY Open-Label, Long-Term Extension
Joshi, Namita , Griffith, Jenny, Song, Alexandra , Kim, Brooke, Platt, Andrew M. , Louis, Édouard , Loftus, Edward V. , Peyrin‐Biroulet, Laurent , Ghosh, Subrata , Shukla, Nidhi , Louis, Edouard
American Journal of Gastroenterology | December 9, 2024 | Volume: 119 | Issue: 12S | Pages: S2-S2
